SBI Securities’s Bone Biologics BBLG Stock Holding History

SBI Securities’s Portfolio BBLG Stock Details BBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$169	Buy	341 +111	+48%	+$91	﹤0.01%	3456
2026 Q2	$315	Hold	230	–	–	﹤0.01%	3185
2026 Q1	$253	Hold	230	–	–	﹤0.01%	3130
2025 Q4	$334	Hold	230	–	–	﹤0.01%	3024
2025 Q3	$642	Buy	+230	New	+$583	﹤0.01%	2874
2025 Q2	–	Hold	0	–	-$1	–	4149
2025 Q1	–	Hold	0	–	–	–	4107
2024 Q4	–	Hold	0	–	–	–	4072

SBI Securities's BBLG Position: Q3 2026 in Review

SBI Securities increased its Bone Biologics (BBLG) stake by 48% in Q3 2026, buying an estimated $91 and bringing the position to 341 shares worth $169. The position accounts for ﹤0.01% of the portfolio, ranked #3456.

SBI Securities first reported a position in BBLG in Q3 2025 and has held it in 5 quarters since. The position peaked at $642 in Q3 2025. 2 funds tracked by Wall St. Rank hold BBLG as of Q3 2026.

SBI Securities held 341 shares of Bone Biologics worth $169 as of Q3 2026.
SBI Securities bought 111 Bone Biologics shares in Q3 2026, an estimated $91.
Bone Biologics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3456 holding.
SBI Securities first reported a position in Bone Biologics in Q3 2025 and has held it in 5 quarters since.
SBI Securities's Bone Biologics position peaked at $642 in Q3 2025.
2 funds tracked by Wall St. Rank held Bone Biologics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.